谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Long-term Safety Profile and Secondary Effectiveness of Canakinumab in Pediatric Rheumatic Diseases: a Single-Center Experience.

Elif Kilic Konte,Nergis Akay,Umit Gul,Kubra Ucak, Ecenur Izzete Derelioglu,Damla Gurleyik,Esma Aslan,Aybuke Gunalp,Fatih Haslak,Mehmet Yildiz,Amra Adrovic,Sezgin Sahin,Kenan Barut,Ozgur Kasapcopur

EXPERT OPINION ON DRUG SAFETY（2024）

引用 0|浏览9
暂无评分
关键词
Anti IL-1,canakinumab,colchicine,event rate,safety
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要